← Leaderboards
Susan T Iannaccone
Ut Southwestern Medical Center
$2,205,326
Attributed
$4,410,651
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2011–24$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,434,686 · 4
By mechanism
P50$8,024,035 · 1
U10$2,158,954 · 1
U24$1,620,000 · 1
U01$631,697 · 1
Top collaborators
- Mark Paul Goldberg9 shared
- Rhonda Bassel-Duby5 shared
- Pradeep P.A. Mammen5 shared
- Eric N Olson5 shared
- Beverly A. Rothermel5 shared
- Jaya R Trivedi5 shared
- Richard B Dewey2 shared
- Steven J Gray1 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Eric N Olson$45,475,240
- Jaya R Trivedi$108,000
- Rhonda Bassel-Duby$9,741,774
- Michael Edward Bowen$4,011,040
- Diane Armao$630,699
Others in their field
Top investigators on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$688,986,350
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Eric S Lander · Whitehead Institute For Biomedical Res$341,717,134
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$311,514,701
Research focus
ResourcesChildMedical CenterResearch PersonnelProgramsCommunitiesInstitutionTrainingTranslatingClinical ResearchUnited States National Institutes Of HealthClinical TrialsNervous System DisorderFoundationsNeuromuscular DiseasesLeadershipNeuromuscularNeurosciencesFutureHispanic AmericansHospitalsClinical Research SiteAdultEnrollment
Grant awards (18)
Myoediting of Duchenne Muscular Dystrophy$1,605,786
P50 · FY2024 · HD
Myoediting of Duchenne Muscular Dystrophy$1,605,786
P50 · FY2023 · HD
IND-enabling studies for Aspartylglucosaminuria (AGU) to support the initiation of an AAV9/AGA gene transfer clinical trial$631,697
U01 · FY2023 · NS
Myoediting of Duchenne Muscular Dystrophy$1,605,786
P50 · FY2022 · HD
UTSW Clinical Research Site for Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)$324,000
U24 · FY2022 · NS
Myoediting of Duchenne Muscular Dystrophy$1,605,786
P50 · FY2021 · HD
UTSW Clinical Research Site for Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)$324,000
U24 · FY2021 · NS
Myoediting of Duchenne Muscular Dystrophy$1,600,891
P50 · FY2020 · HD
UTSW Clinical Research Site for Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)$324,000
U24 · FY2020 · NS
UTSW Clinical Research Site for Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)$324,000
U24 · FY2019 · NS
UTSW Clinical Research Site for Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)$324,000
U24 · FY2018 · NS
Network of Excellence in Neuroscience Clinical Trial (NEXT)$318,000
U10 · FY2017 · NS
Network of Excellence in Neuroscience Clinical Trial (NEXT)$318,000
U10 · FY2016 · NS
Network of Excellence in Neuroscience Clinical Trial (NEXT)$318,000
U10 · FY2015 · NS
Network of Excellence in Neuroscience Clinical Trial (NEXT)$308,798
U10 · FY2014 · NS
Network of Excellence in Neuroscience Clinical Trial (NEXT)$261,156
U10 · FY2013 · NS
Network of Excellence in Neuroscience Clinical Trial (NEXT)$318,000
U10 · FY2012 · NS
Network of Excellence in Neuroscience Clinical Trial (NEXT)$317,000
U10 · FY2011 · NS